Enterostatin (human, mouse, rat) (trifluoroacetate salt)
(Synonyms: APGPR) 目录号 : GC49324A pentapeptide involved in the regulation of food intake
Sample solution is provided at 25 µL, 10mM.
Enterostatin is an endogenous pentapeptide fragment involved in the regulation of food intake.1 It is released from its precursor protein, procolipase, during digestion and acts in the peripheral and central nervous systems to reduce food, especially fat, intake through the vagus nerve in the periphery and κ-opioid-, serotonin (5-HT) receptor subtype 5-HT1B-, and cholecystokinin-mediated signaling pathways in the brain.1,2 Enterostatin binds to mitochondrial complex V, also known as F1F0 ATP synthase, in a cell-free assay and inhibits ATP production and increases thermogenesis in INS-1 insulinoma cells.3 It reduces body weight in rats fed a high-fat diet but not mice fed a chow diet. Enterostatin (1 nmol, i.c.v) reduces food intake in wild-type, but not melanocortin receptor 4 knockout (Mc4r-/-), mice.4 It also enhances memory consolidation in mice in a passive avoidance test when administered at a dose of 300 mg/kg, an effect that can be blocked by the cholecystokinin 1 (CCK1) receptor antagonist lorglumide .5
1.York, D.A., and Park, M.Enterostatin, a peptide regulator of dietary fat ingestionHandbook of biologically active peptides969-974(2006) 2.Lin, L., and York, D.A.5-HT1B receptors modulate the feeding inhibitory effects of enterostatinBrain Res.1062(1-2)26-31(2005) 3.Berger, K., Sivars, U., Winzell, M.S., et al.Mitochondrial ATP synthase—a possible target protein in the regulation of energy metabolism in vitro and in vivoNurtr. Neurosci.5(3)201-210(2002) 4.Lin, L., Park, M., and York, D.A.Enterostatin inhibition of dietary fat intake is modulated through the melanocortin systemPeptides28(3)643-649(2007) 5.Ohinata, K., Sonoda, S., Shimano, T., et al.Enterostatin (APGPR) enhances memory consolidation in micePeptides28(3)719-721(2007)
Cas No. | N/A | SDF | |
别名 | APGPR | ||
Canonical SMILES | N=C(N)NCCC[C@@H](C(O)=O)NC([C@H]1N(C(CNC([C@H]2N(C([C@H](C)N)=O)CCC2)=O)=O)CCC1)=O.OC(C(F)(F)F)=O | ||
分子式 | C21H36N8O6·XCF3COOH | 分子量 | 496.6 |
溶解度 | DMF: 30 mg/ml,DMSO: 25 mg/ml,Ethanol: 30 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.0137 mL | 10.0685 mL | 20.1369 mL |
5 mM | 0.4027 mL | 2.0137 mL | 4.0274 mL |
10 mM | 0.2014 mL | 1.0068 mL | 2.0137 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet